Inventaire - your friends and communities are your best library

Phosphodiesterase inhibitors. Do the risks outweight the benefits?

Published in: Drug Safety

Date of publication: December 1, 1993

Bibliographic databases:

Cites articles 36

Date

Title

Authors

October 1, 1980

Contrasting immediate and long-term effects of isosorbide dinitrate on exercise capacity in congestive heart failure
January 1, 1981

Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure
May 1, 1983

Sustained hemodynamic and clinical effects of a new cardiotonic agent, WIN 47203, in patients with severe congestive heart failure
October 1, 1983

A placebo-controlled trial of captopril in refractory chronic congestive heart failure. Captopril Multicenter Research Group
June 1, 1984

Exercise intolerance in patients with chronic heart failure: role of impaired nutritive flow to skeletal muscle
November 1, 1984

Oral amrinone for the treatment of chronic congestive heart failure: results of a multicenter randomized double-blind and placebo-controlled withdrawal study
August 1, 1985

Milrinone in congestive heart failure: acute and chronic hemodynamic and clinical evaluation
May 1, 1985

Effects of intracoronary and intravenous amrinone infusions in patients with cardiac failure and patients with near normal cardiac function
May 1, 1985

Long-term oral administration of amrinone for congestive heart failure: lack of efficacy in a multicenter controlled trial
July 1, 1985

Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis
March 1, 1986

Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness
October 1, 1986

Symptomatic assessment of patients with heart failure: double-blind comparison of increasing doses of diuretics and captopril in moderate heart failure
March 1, 1986

Milrinone, dobutamine, and nitroprusside: comparative effects on hemodynamics and myocardial energetics in patients with severe congestive heart failure
January 1, 1986

Separation of the direct myocardial and vasodilator actions of milrinone administered by an intracoronary infusion technique
January 1, 1986

Abnormalities of the peripheral circulation and respiratory function in patients with severe heart failure
May 1, 1986

Systemic and coronary effects of intravenous milrinone and dobutamine in congestive heart failure
June 1, 1987

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).
July 1, 1987

Hemodynamic and regional blood flow response to milrinone in patients with severe congestive heart failure: a dose-ranging study
April 1, 1987

Efficacy and safety of sustained (48 hour) intravenous infusions of milrinone in patients with severe congestive heart failure: a multicenter study
July 1, 1987

New inotropic drugs for heart failure
August 1, 1987

Intravenous use of enoximone
September 1, 1988

Administration of enoximone in cardiogenic shock
January 1, 1989

Effect of phosphodiesterase inhibition on myocardial oxygen consumption and coronary blood flow
March 1, 1989

A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure
September 1, 1989

Comparison of the effects of captopril and enoximone in patients with severe heart failure: a placebo controlled double-blind study
March 1, 1989

Inotropic therapy for heart failure: paradise postponed
October 1, 1989

Improving exercise tolerance in patients with chronic heart failure: should we treat the heart or the periphery? VO2 French Study Group
July 1990

Effects of enoximone in patients with heart failure uncontrolled by captopril and diuretics
September 1, 1990

Multicenter trial of oral enoximone in patients with moderate to moderately severe congestive heart failure. Lack of benefit compared with placebo. Enoximone Multicenter Trial Group
September 1, 1990

Comparison of the hemodynamic effects of dobutamine and enoximone in the treatment of low cardiac output after valvular surgery
October 1990

Enoximone: true inotropic effects? Do they cause ischemia? Analysis of end-systolic pressure-volume relations using the conductance (volume) catheter technique
November 1, 1991

Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group

Article -

Welcome to inventaire

The library of your friends and communities

Learn more